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Abstract
Background and aims Little is known about the intestinal
epithelial expression and secretion of CXCL10 (IP-10), a
chemokine involved in recruiting T cells and monocytes.
We aimed to study CXCL10 gene expression and regula-
tion by the pro-inflammatory cytokines interleukin (IL)-1β,
interferon (IFN)-γ and tumour necrosis factor (TNF)-α in
intestinal epithelial cell lines.
Materials and methods CXCL10 expression and secretion
kinetics were assessed in Caco-2, HT-29 and DLD1 human
colon epithelial cells, treated with IL-1β, TNF-α, IFN-γ
alone or in combination with each other by real-time
polymerase chain reaction (PCR), Northern blotting and
enzyme-linked immunoabsorbent assay (ELISA). Transient
transfections with TGL-IP10 (CXCL10 promoter) and
TGL-IP10-κB2 mutant promoter and gelshifts and super-
shifts for nuclear factor (NF)-κB were also performed.
Results Real-time PCRs and ELISA experiments revealed
that IL-1β was the strongest and earliest inducer of
CXCL10 messenger ribonucleic acid (mRNA) expression
and protein secretion in Caco-2 cell line, whereas INF-γ
had a delayed kinetics. There was a strong synergistic effect
of either TNF-α or IL-1β with IFN-γ both on CXCL10
mRNA expression and protein secretion in all three cell lines.
Real-time PCR and ELISA experiments using a specific NF-
κB inhibitor and transfection experiments with a NF-κB-
binding defective CXCL10 promoter construct revealed that
the induction of CXCL10 by IL-1β and its synergism with
IFN-γ is NF-κB dependent.
Conclusion These data demonstrate that in colonic epithe-
lial cells, depending on the cellular context and utilizing the
NF-κB pathway, IL-1β alone and/or in synergism with
IFN-γ may play a major role in the induction of CXCL10.
Keywords Intestinalepithelialcells.
Nuclear factorkappaB.Inflammatoryboweldisease.
Cytokinesandchemokines.Coloncancer
Introduction
Intestinal epithelial cells (IECs) form the first immunologic
barrier of the organism while the villus surface is
continuously in contact with various agents. IEC gene
expression is tightly regulated to induce appropriate
responses to pathogens and to avoid deleterious reactions
to microbial flora. When stimulated with pro-inflammatory
cytokines or infected with microbial pathogens, IECs may
secrete chemokines, a set of low-molecular weight cyto-
kines, directing migration and activation of leucocytes,
which play a major role in the perpetuation of inflammatory
processes [1–5]. The final composition of leucocytes
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30625 Hannover, Germanypresent in the inflamed intestine is most likely due to both
secreted chemokines and the relative expression of chemo-
kine cell surface receptors on different cell types. Chemo-
kine production by colonic epithelial cells is thought to
contribute to the characteristic increased infiltration of
selected populations of leucocyte cells in inflammatory
bowel disease (IBD) [6, 7].
CXCL10 is a CXC chemokine, known to be secreted by
endothelial cells [8], keratinocytes [9], eosinophils [10] and
neutrophils [11]. It is also constitutively expressed by
normal human colon epithelium [12] and chemoattracts
activated T cells as well as monocytes by binding to the
CXCR3 receptors present on the respective cells [13, 14].
While CXCL10 up-regulation may occur in acute inflam-
mation in response to pathogens, it is also known to be
p e r m a n e n t l yo v e r - e x p r e s s e di nI B Dp a t i e n t s[ 15, 16].
Blocking CXCL10 could prevent mice from acute colitis,
suggesting this chemokine to play an important role in IBD
pathogenesis [17]. Moreover, CXCL10 is believed to
possess anti-tumoural properties by promoting anti-tumour
T cell immunity [18, 19]. Knowledge of its regulation in
colonic cell lines may therefore give also insight into the
pathobiology of colorectal cancer.
Most previous studies on chemokine expression in IEC
concentrated on CXCL8 (interleukin [IL]-8), a neutrophil
chemoattractant [20, 21], but there were only few studies
regarding the expression and secretion of CXCL10 in IECs
[12]. Although it is well known that interferon (IFN)-γ is a
major inducer of CXCL10 and that CXCL10 expression
may be enhanced by pathogens and other inflammatory
cytokines, the relative contribution of cytokines on CXCL10
induction, their synergistic action and the kinetics of
cytokine-induced CXCL10 expression in intestinal epithelial
cells has not been fully elucidated. Especially, the role of IL-
1β in CXCL10 gene regulation in IECs and also in other cell
types has not been fully evaluated so far. Intestinal mucosa is
composed of cell populations in continuous change from a
proliferative and undifferentiated stage in the basal parts of
crypts to mature surface villus epithelial cells [22, 23]. Little
is known about the alteration of immunological functions as
IECs mature. It has been shown that cellular differentiation
affects IEC responsiveness to IL-1β [24].
In the present study, we aimed to elucidate the role of the
pro-inflammatory cytokines IL-1β, tumour necrosis factor
(TNF)-α and IFN-γ, which have established role in IBD
pathogenesis, in inducing CXCL10 gene expression in IEC
lines. Especially, the role of IL-1β, one of the most
abundantly expressed cytokines, both in normal and
inflamed mucosa [25], in inducing CXCL10 expression
by IECs and its possible signalling mechanisms was given
importance. To consider possible influences of cellular
differentiation on cytokine responsiveness, we performed
studies on three different colonic epithelial cell lines. Our
findings will get an insight into the role of intestinal
epithelium in immune responses and in evaluating pathways,
whichmight betargetsofpresent and futurepharmacotherapy
of IBD and possibly colorectal cancer.
Materials and methods
Biological reagents
The recombinant cytokines IL-1β, TNF-α and IFN-γ were
purchased from Roche applied science (Mannheim, Ger-
many). An enzyme-linked immunosorbent assay (ELISA)
kit for CXCL10 was purchased from RnD systems
(Weisbaden, Germany). The nuclear factor (NF)-κB inhib-
itor BAY11-7082 was purchased from Calbiochem (San
Diego, CA).
Cell culture and stimulation protocols
The human colon adenocarcinoma cell lines Caco-2, HT-29
and DLD1 were obtained from DSMZ (Braunschweig,
Germany). Caco-2 cells were grown in Eagle’s minimal
essential medium (BioWhittacker, Germany) containing
20% foetal calf serum (FCS) supplemented with 100 U/ml
each of penicillin and streptomycin and 1% non-essential
amino acids at 37°C and 5% CO2. HT29 and DLD1 were
grown in Roswell Park Memorial Institute medium con-
taining 10% FCS and 100 U/ml penicillin and streptomycin
at 37°C and 5% CO2. Caco-2, HT29 and DLD-1 cells were
plated into six-well plates at a density of 5×10
5 cells per
well for real-time polymerase chain reactions (PCRs),
ELISA, Northern blotting and electrophoresis mobility shift
assay (EMSA) experiments unless until stated and grown
till they reached 70–80% confluence. These cells were then
stimulatedwith IL-1β(0.1,0.5,1,2,10and50ng/ml),TNF-α
(2, 10 and 50 ng/ml) and IFN-γ (2, 10 and 50 ng/ml) based on
the type of experiments.
RNA isolation, real-time PCR
Ribonucleic acid (RNA) was isolated by using Qiagen
RNeasy mini kit according to the manufacturer’sp r o t o c o l .
The RNA concentrations were determined photometrically
using a Gene Quant RNA/deoxyribonucleic acid (DNA)
calculator (Pharmacia, Freiburg, Germany). RNAwas subse-
quently used for real-time PCR and Northern blot analysis.
Reverse transcription of messenger RNA (mRNA) was
performed using 1 μg of total cellular RNA. To determine
themRNAexpressionofCXCL10,real-timePCRwascarried
out using gene-specific primers for human CXCL10 (Invi-
trogen GmbH, Karlsruhe) forward 5′-CCA GAATCG AAG
GCC ATC AA-3′,r e v e r s e5 ′-CAT TTC CTT GCTAAC TGC
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GCA CCC AGC ACA ATG-3′,r e v e r s e5 ′-CCG ATC CAC
ACG GAG TAC TTG-3′ in an ABI Prism 7000 sequence
detection system. PCR reaction was set up with Sybr® Green
PCR Master mix (Invitrogen) containing 0.3 μmol/l primers
each and 1 μlo fR T - p r o d u c ti n2 5μl volume. A two-step
amplification protocol was chosen consisting of initial dena-
turation at 95°C for 10 min followed by 45 cycles with 15 s
denaturation at 95°C and 30 s annealing/extension at 60°C.
Finally, a dissociation protocol was performed to control
specificity of amplification products.
Relative expression of CXCL10 was then calculated using
the comparative threshold-cycle (CT) method. The amount of
targetmRNAineachsamplewasnormalizedtotheamountof
β-actin mRNA designated as calibrator, to give ΔCT (CT β-
actin−CTCXCL10).TherelativeexpressionofCXCL10was
calculated as the CXCL10=β   actin ratio ¼ 2$CT.M R N A
expression is presented as fold increase calculated in relation
to unstimulated cells after normalization to β-actin.
Transient transfections
Caco-2, HT29 and DLD1 cells were plated in 24-well
plates, 24 h before transfection (Costar, Corning, NY), at a
density of 50,000/well in 1 ml medium. After 24 h, the cells
were transfected with 250 ng of respective plasmids along
with 20 ng of renilla plasmid using the non-liposomal
formulation FuGENE (Roche Molecular Biochemicals,
Mannheim, Germany). On the day of transfection, fresh
medium was added. FuGENE was added to the plasmid
DNA at a ratio of 3 μl/μg DNA. FuGENE was prediluted
in 100 μl serum-free medium and added drop-wise to the
concentrated plasmid DNA. After 15–25 min at room
temperature, the mixture was added to the cells. The
plasmids TGL-IP10, TGL-IP10 κB2 Mut were kind gifts
from Dr. Richard M. Ranshoff (Cleveland, OH) and were
described elsewhere [26].
Luciferase assays
Twenty-four hours after transfection, cells were stimulated
with IL-1β (0.1,1, 2, 10 and 50 ng/ml), TNF-α (2, 10 and
50 ng/ml), IFN-γ (2, 10 and 50 ng/ml), IL-1β (1 ng/ml)+
TNFα (50 ng/ml), IL-1β (1 ng/ml) + IFN-γ (50 ng/ml) and
TNFα (50 ng/ml)+IFN-γ (50 ng/ml) for 24 h, harvested
and lysed, and luciferase was assayed by using a luciferase
kit (Promega). Values were normalised to renilla luciferase.
Enzyme-linked immunosorbent assay
To study the synergistic effects of cytokines on CXCL10
secretion, supernatants were collected at 0, 3, 6, 12 and 24 h
in Caco-2 and HT29 cells stimulated with IL-1β (1 ng/ml),
TNF-α (50 ng/ml), IFN-γ (50 ng/ml), IL-1β (0.5 ng/ml)+
TNFα (50 ng/ml), IL-1β (0.5 ng/ml)+IFN-γ (50 ng/ml) and
TNFα (50 ng/ml)+IFN-γ (50 ng/ml) and stored at −70°C
until measured. CXCL10 protein secretion was measured by
ELISA according to the manufacturer’s protocol.
Preparation of nuclear extract
Caco-2cellsweregrownfor24h,pre-treatedfor1hwithBAY
11-7082 (10 μM) and then stimulated with respective
cytokines for 30 min. Cells were washed with 10 ml cold
phosphate-buffered saline (PBS) twice, harvested, centrifuged
at 1,000×g for 5 min and resuspended in 1 ml of cold PBS.
Centrifuged briefly, excess PBS was removed, and the pellet
was resuspended in ice-cold extraction buffer (20 mM
hydroxyethyl piperazineethanesulfonic acid [HEPES]
pH 7.8, 10 mM KCL, 0.1 mM ethylenediamine tetraacetic
acid [EDTA], 1 mM dithiothreitol and 0.5 mM phenyl-
methanesulphonylfluoride [PMSF]) by gentle pippeting. Cells
were then kept on ice for 15 min, and 30 μl of 10% Nonidet
NP-40 was added and vortexed briefly for 10 s. The lysed
cell suspension was centrifuged for 30 s, and the supernatant
was discarded. The pellet was resuspended in 50 μl extraction
buffer containing 400 mM NaCl, agitated vigorously for
15 min at 4°C. Then, the cell suspension was centrifuged for
5 min at 4°C, and the supernatant containing the nuclear
extract was collected and stored at −80°C until further use.
Electrophoretic mobility shift assay and super-shift assay
For binding reactions, 5 μg of nuclear extracts were
incubated in 20 μl reaction mixture containing 40 mM
HEPES pH 7.5, 50 mM NaCl, 1 mM EDTA, 1mM
DithitreitolHSCl,1mMPMSF,1.28μg/mlpBluescriptvector
DNA as half of the reaction and the rest being nuclear extract
plus other components. Oligonucleotide duplex probes
(Promega) were end-labelled with T4 polynucleotide kinase
and [γ
32P] adenosine triphosphate; 1×10
4 cpm were then
added to the reaction mixtures and incubated overnight at
4°C. Reaction products were analysed by non-denaturing
electrophoresis in a 5% polycralamide gel with 0.5× Tris–
borate–EDTA buffer at room temperature. Gels were then
exposed directly to X-ray film at −70°C for autoradiography.
For competition, unlabelled oligonucleotides were added in
molar excess at room temperature for 15 min before adding
radiolabelled probe. In super shift experiments, nuclear
extracts were incubated with anti-p65 anti-body (Santa Cruz
Biotechnology, Santa Cruz, CA) overnight at 4°C.
Statistical analysis
Statistical analyses were carried out using the Prism
software packet (Version 3.0, Graphpad Software, San
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treatment groups were made with the non-paired t test or
analysis of variance (ANOVA) where appropriate. For time
kinetics experiments, a two-way ANOVA test followed by
the Bonferroni post-test was performed. In case of RNA
expression, a log transformation was performed before.
Statistical differences were regarded significant at a p level
below 0.05. Data were expressed as means±standard error of
the mean (SEM).
Results
Differential expression of CXCL10 mRNA in intestinal
epithelial cell lines under basal conditions
In the present study, the basal mRNA expression of
CXCL10 in three different IECs, Caco-2, HT29 and
DLD1 cells, were studied first. Real-time PCR experiments
using gene-specific primers for CXCL10 revealed that the
basal mRNA expression of CXCL10 was highest in Caco-2
followed by HT29 and DLD1 (Fig. 1).
IL-1β, TNF-α and IFN-γ dose-dependent influence
on CXCL10 gene expression in IECs
Caco-2, HT29 and DLD1 cells were tested for their
ability to respond to pro-inflammatory cytokines by the
induction of CXCL10 mRNA expression. Cells were
stimulated for 4 h with various concentrations of
cytokines, and CXCL10 expression was analysed by
real-time PCR. In response to IFN-γ and TNF-α,C a c o -
2, HT29 and DLD1 cells showed a dose-dependent
induction of CXCL10 mRNA (Fig. 2). Increased expres-
sion of CXCL10 mRNA was observed when 2 ng/ml IL-
1β was used, while a higher concentration did not further
enhance expression. Further, we checked the response of
IECs to lower doses of IL-1β showing a dose response in
the range of 0.1 to 1 ng/ml in the induction of CXCL10
mRNA. IL-1β at a concentration of 0.5 ng/ml was able to
induce maximum expression of CXCL10 mRNA at 4 h
(data not shown).
IL-1β, TNF-α and IFN-γ time-dependent influence
on CXCL10 gene expression in IECs
Once we confirmed the responsiveness of IECs to pro-
inflammatory cytokines, we next examined the mRNA
kinetics of CXCL10 induced by the cytokines alone or in
combination with each other. Each cell line had a different
time course of response when stimulated with respective
cytokines and their combinations (Fig. 3a–c). In Caco-2,
stimulated with IL-1β or TNF-α,C X C L 1 0m R N Aw a s
induced within the first 40 min, and the induction reached
to a peak after 4 h, while IFN-γ had a later initial effect
i n d u c i n gC X C L 1 0m R N Aa f t e r2ha n dr e a c h e dt oa
maximum at 8 h. Combination of IL-1β+IFN-γ had a
stronger synergistic effect in the induction of CXCL10
mRNA within 20 min and reaching to maximum after 4 h,
whereas TNF-α+IFN-γ synergistically led to a later
induction of CXCL10 mRNA starting at 40 min but had
a strong synergistic effect after 8 h when compared to IL-
1β+IFN-γ (Fig. 3a ) .I nH T 2 9( F i g .3b) and DLD1
(Fig. 3c), CXCL10 mRNA time kinetics deviated from
that in Caco-2 (Fig. 3a). CXCL10 mRNA was induced
after 1 h of stimulation with the respective single
cytokines in DLD1. In case of HT29, either TNF-α or
IFN-γ alone led to delayed induction of CXCL10 mRNA
after 1 h, whereas IL-1β alone led to an induction starting
at 2 h. HT29 and DLD1 cells treated with combinations of
IL-1β+IFN-γ showed a strong synergistic induction of
CXCL10 mRNA within 40 min, whereas the TNF-α+
IFN-γ combination led to an even stronger induction of
CXCL10 mRNA within 20 min in HT29 and within
40 min in DLD1. IL-1β+TNFα in combination had no
synergistic effect on CXCL10 mRNA induction in all the
cell lines used for this study. The real-time PCR results
could be confirmed by Northern blot analysis in Caco-2
and HT29 cells. However, the detection threshold was not
low enough to display basal and single cytokine-induced
CXCL10 mRNA (data not shown).
Fig. 1 Basal level expression of CXCL10 in IECs. Caco-2, HT29 and
DLD1 cells were plated at a density of 5×10
5 cells in six well plates,
grown for 24 h and total RNA from the cells was isolated. First-strand
complementary DNAwas prepared from 1 μg of total RNA. Real-time
PCR was performed for CXCL10 and β-actin was used as an internal
control. The bars indicate the mean of six individual experiments.
Asterisk corresponds to p<0.01
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To test whether cytokine stimulation of IECs would lead
not only to the induction of CXCL10 mRNA but also to the
synthesis and secretion of the protein, Caco-2, HT29 and
DLD1 cells were incubated with respective cytokines (from
3 to 24 h), and secretion of CXCL10 was detected by
ELISA. Under basal conditions, Caco-2 cells secreted
0.012±0.003 ng/ml CXCL10. Treatment with IL-1β,
TNF-α and IFN-γ led to a time-dependent increase in
CXCL10 protein, with IL-1β being the most potent
stimulus during the first 6 h (Fig. 4a). Of importance, after
12 h, CXCL10 secretion was stimulated strongly by IFN-γ.
Co-incubation of Caco-2 with respective cytokines revealed
a synergistic effect of IL-1β+IFN-γ and TNF-α+IFN-γ on
CXCL10 secretion, reaching levels of 3.354±0.690 and
7.808.1±0.173 ng/ml after 24 h. The combination of IL-1β+
TNF-α had no synergistic effect on CXCL10 secretion
when compared to the respective cytokines alone. These
time kinetic studies revealed that in Caco-2, IL-1β alone or
in combination with IFN-γ induced the secretion of
CXCL10 very early compared to the combination of
TNF-α+IFN-γ, which induced a delayed but stronger
synergistic secretion of CXCL10 protein, suggesting that
in case of IL-1β+IFN-γ, a synergism could take place very
early, e.g., at the level of intracellular signal cascades. In
HT29 cultures, CXCL10 secretion was not detectable under
basal condition. TNF-α or IFN-γ alone led to an induction
of CXCL10 protein secretion within 3 h (0.0172±0.005 and
0.011±0.001 ng/ml), whereas IL-1β could not induce the
secretion of CXCL10 protein. IL-1β, TNF-α and IFN-γ led
to a time-dependent increase in CXCL10 concentrations in
HT29 cell supernatants reaching maximum levels of 0.039±
0.0057, 0.632±0.0222 and 19.929±0.838 ng/ml showing
that IFN-γ is the strongest inducer of CXCL10 protein
secretion when compared to other two cytokines in this cell
line (Fig. 4b). The combinations of TNFα+IFN-γ and IL-
1β+IFN-γ induced CXCL10 protein secretion to 1.822±
0.109 and 0.410±0.027 ng/ml within 3 h and led to a
maximum of 492.728±83.776 and 87.158±7.913 ng/ml after
24 h (Fig. 4b).
CXCL10 promoter activation by cytokines
TGL-IP10, a promoter-reporter containing 435 bp of human
CXCL10 sequence upstream of the transcriptional start site,
was used to evaluate the role of IL-1β, TNF-α and IFN-γ
alone or in combination with each other in the transcription of
CXCL10. When TGL-IP10-transfected Caco-2 cells were
stimulated with single cytokines, IL-1β (1 ng/ml) led to a
stronger induction (6.53±1.65-fold increase) than TNF-α
(50 ng/ml)and IFN-γ (50ng/ml) alone (2.76±0.53and3.14±
1.2-fold increase). The combination of IL-1β+IFN-γ showed
a stronger synergistic induction (26.18±11.68) than the
combination of TNF-α+IFN-γ (13.97±3.25-fold increase)
(Fig. 5a). In HT29 cells, when stimulated with single
cytokines, IFN-γ (50 ng/ml) led to a maximum induction
(6.52±0.58-fold increase), followed by TNF-α (4.44±0.16-
fold increase) and IL-1β (1.43±0.05-fold increase). The
combination of IL-1β+IFN-γ synergistically led to 12.76±
3.21-fold induction, and TNF-α+IFN-γ led to 26.70±7.5-
fold induction of promoter activity (Fig. 5b). In DLD1 cells
(Fig. 5c), IFN-γ (50 ng/ml) led to a maximum induction
(8.06±0.51-fold increase) of CXCL10 promoter activity
followed by TNF-α (50 ng/ml) induction (3.59±0.08-fold
increase) and IL-1β (1 ng/ml) induction (2.32±0.12-fold
increase). The combination of IL-1β+IFN-γ led to a 40.72±
12.19-fold induction, and TNF-α+IFN-γ led to a 20.56±
6.27 fold induction. In all three cell lines, the combination of
Fig. 2 Dose-dependent expression of CXCL10 mRNA in IECs
stimulated with cytokines. 5×10
5 cells were plated into six-well
plates and grown for 24 h and then stimulated with IL-1β, TNF-α and
IFN-γ at an increasing doses of 2, 10 and 50 ng/ml. The cells were
harvested after 4 h, total RNA from the cells was isolated, and first-
strand cDNA was prepared from 1 μg of total RNA. Real-time PCR
was performed for CXCL10, and β-actin was used as an internal
control. Graph represents the mean±SEM of four individual experi-
ments. All cytokine-stimulated expressions were significantly different
from unstimulated controls (p<0.05). Asterisk, no significant differ-
ence between different IL-1β concentrations (p<0.05)
Int J Colorectal Dis (2008) 23:305–317 309310 Int J Colorectal Dis (2008) 23:305–317IL-1β+TNF-α h a dn os y n e r g i s t i ce f f e c to nC X C L 1 0
promoter activity.
Evaluating the role of NF-κB in CXCL10 gene expression
To evaluate the possible role of NF-κB in cytokine-induced
CXCL10 gene expression, experiments with a specific NF-
κB inhibitor were performed. The effect of BAY 11-7082
on NF-κB inhibition was evaluated by reporter assays.
BAY11-7082 was able to dose-dependently inhibit IL-1β-
induced pNF-κB-SEAP gene reporter activity in Caco-2
cells (data not shown). Based on this experiment, we could
determine that 10 μM of BAY11-7082 was sufficient to
inhibit the NF-κB activation.
The induction of CXCL10 gene expression by cytokines
was inhibited by addition of the NF-κB-specific inhibitor
BAY11-7082 in Caco-2, HT29 and DLD1 cells, with a
varying degree of inhibition in the individual cell lines.
Inhibition of NF-κB led to almost complete inhibition
(approximately 90–95% inhibition) of CXCL10 mRNA
and protein secretion induced by cytokines in Caco-2 and
DLD1 cells (Fig. 6a and c). In DLD1 cells, IL-1β (1 ng/ml)
did not have any inducing effect on CXCL10 secretion. In
HT29, inhibition of NF-κB had approximately 60–75%
inhibitory effect on cytokine-induced CXCL10 mRNA
expression and secretion (Fig. 6b).
To further evaluate the role of NF-κB, transient trans-
fections were done with a CXCL10 promoter construct
bearing a mutated NFkB-binding site (TGL-IP10 κB2 Mut).
In Caco-2 cells, TGL-IP10 κB2 Mut was not responsive to
any of the cytokines and their combinations, suggesting that
CXCL10 gene induction is strongly dependent on NF-κBi n
this cell line (Fig. 7a). In HT29 and DLD1 cells, the
combination of TNF-α+IFN-γ led to 6.49±2.13 and 4.87±
1.43-fold increase, and the combination of IL-1β+IFN-γ
led to 2.26±0.63 and 4.75±0.53-fold increase of the TGL-
IP10 κB2 Mut promoter activity (Fig. 7b and c), revealing
that a smaller portion of CXCL10 gene expression might be
regulated independently from NF-κB.
To confirm further our results from promoter and
inhibitor studies, we did gel-shift and super shift assays to
show that NF-κB is activated by cytokines and that the
activated NF-κB complex contains the NF-κB functional
sub-unit p65. In the nuclear extracts of Caco-2 cells, we
could clearly see a shift in the samples treated with IL-1β,
TNF-α alone or the combinations of IL-1β+IFN-γ and
TNF-α+IFN-γ. The protein-DNA complex was efficiently
competed by unlabelled κB oligonucleotides. There was no
shift in the samples treated with the NF-κB inhibitor
BAY11-7082, stating that the shift was indeed because of
NF-κB binding. Furthermore, antibody super shift assay
using anti-p65 antibody had clearly shown that the complex
contains NF-κB functional sub-unit, p65 (Fig. 8).
Fig. 4 Time kinetics of CXCL10 protein secretion in Caco-2 and
HT29 cells stimulated with cytokines. 5×10
5 cells were plated into
six-well plates and grown for 24 h and then stimulated with IL-1β,
TNF-α and IFN-γ as indicated. Supernatants were collected at
respective time points from a Caco-2 and b HT29 cells and ELISA
for CXCL10 protein was performed. Data represent means of three to
five experiments±SEM done in duplicates for each sample. Asterisk
indicates time points with significant differences (p<0.05) of cytokine
combinations compared to IFN-γ alone
Fig. 3 Time kinetics of CXCL10 mRNA expression in IECs stimulated
with cytokines. a Caco-2, b HT29 and c DLD1 cells were plated at a
density of 5×10
5 cells in six-well plates and grown for 24 h and then
stimulated with respective cytokines and their combinations. Cells were
harvested at different time points as indicated, and total RNA from the
cells was isolated and first-strand cDNA was prepared from 1 μgo ft o t a l
RNA. Real-time PCR was performed for CXCL10, and β-actin was used
as an internal control. Graphs represent the mean±SEM of three to five
experiments. IFN-γ led to a significant increase in CXCL10 expression
from 2 h onwards. A significant increase (p<0.05) from control was
observed in all expect in those marked as N.S. (non-significant). Number
sign indicates time points with significant differences (p<0.05) of
cytokine combinations or IL-1β compared to IFN-γ alone

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In addition to its many homeostatic functions such as
barrier protection, mucus production and resorption, the
intestinal epithelium plays an important role in regulating
local inflammation and immune responses. The intestinal
epithelium participates in inflammatory responses in part
through the generation of numerous cytokines and chemo-
kines that mediate recruitment and activation of inflamma-
tory cells. The epithelium is involved in local cytokine
networks allowing first response to noxious agents as well
as cross-talk with immune cells to help provide an effective
inflammatory response. These bi-directional inflammatory
communications are necessary for normal host defence, but
they also play an important role in the pathogenesis of IBD
and might be also of importance in modulating anti-
tumoural immunity in colonic malignancies. In this report,
we demonstrate that pro-inflammatory cytokines, which
may be produced by sub-mucosal immune cells, can
differentially and co-ordinately regulate CXCL10 gene
expression in IECs.
CXCL10 is one of several chemokines produced by IEC.
Previous studies could show that IFN-γ in combination
with TNF-α caused induction of RANTES (regulated upon
activation, normal t-cell expressed, and secreted protein)
and monocyte chemotactic protein-1 in colorectal tumour
cell lines, while IFN-γ had no effect on CXCL8 (IL-8)
secretion [27], the latter observation being confirmed in all
three cell lines in the present study (data not shown).
Dwinell et al. [12] had previously shown that stimulation
of IECs with TNF-α or IL-1α strongly potentiated IFN-γ-
induced CXCL10. It is well known that among IL-1α and
IL-1β, the latter is secreted and has an active role in
inflammation. Importantly, IL-1β was shown to be over-
expressed in IBD patients [25, 28]. This makes IL-1β an
Fig. 5 Transient transfection analysis of TGL-IP10 in IECs. The
CXCL10 promoter containing reporter construct, pTGL-IP10 and
pRL-TK (renilla) plasmids, was transiently transfected into a Caco-2,
b HT29 and c DLD1 cells. 24 h after transfection, cells were
stimulated with cytokines as indicated for 24 h, harvested, and
promoter activity was monitored by luciferase assay. Data were
normalised with renilla luciferase values and included as fold increase
vs control. Data represent the means±SEM of three to five
independent experiments done in duplicates for each sample. Asterisk
indicates an induction significantly different (p<0.05) from control
(C). Significant differences between combinations of cytokines and
the respective single cytokines are indicated with bars with a number
sign (p<0.05). N.S. is not significant
Fig. 6 Role of NF-κB in cytokine-induced CXCL10 mRNA
expression by IECs. 5×10
5 cells were plated and grown for 24 h.
Then, the cells were pre-treated with 10 μM of BAY 11-7082 for 1 h
and then stimulated with respective cytokines and their combinations
as stated in the figure for 2 and 24 h. After 2 h, cells were harvested
for RNA isolation to perform real-time PCRs, and at 24 h, cell
supernatants were collected and stored at −70°C until ELISA was
performed for CXCL10. Data presented are the means±SEM of three
independent experiments done in duplicates for each sample in a
Caco-2, b HT29 and c DLD1 cells. Significant CXCL10 inhibition by
BAY 11-7082 is indicated by an asterisk (p< 0.05). N.S. is not
significant
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regulation. Although the synergistic effects of TNF-α+
IFN-γ on CXCL10 gene expression and the signalling
mechanisms involved were studied in astrocytes [26] and
their synergistic effect on inducible nitric oxide synthase
expression in IECs and macrophages [29] had been studied
in detail, the synergistic action of these cytokines on
CXCL10 gene expression and the signalling mechanisms
involved have not been evaluated in IECs. Especially, the
role of IL-1β alone and its synergism with both TNF-α and
IFN-γ on CXCL10 gene expression in IECs has been given
no attention.
Previously, it has been shown that IECs may express
elevated levels of CXCL10 [12], and its expression is
increased in the mucosa of patients with IBD [16]. A
critical role for CXCL10 in IBD has also been shown in
animal models [30, 31]. Apart from this, CXCL10 has been
shown to be expressed constitutively in colorectal carcino-
mas and primary metastatic sites exerting anti-tumour
activity by recruiting mononuclear cells via the CXCR3
receptor. However, at the same time, it has also been shown
that CXCL10 promoted metastatic adhesion and tumour
cell migration [32] so that care should be taken considering
CXCL10 as an anti-tumoural therapy option.
In light of these findings, we assessed whether stimulation
of IECs in culture by inflammatory mediators could induce
CXCL10 gene expression. All three IEC lines we used
expressed CXCL10 mRNA in a concentration-dependent
manner when stimulated with IFN-γ and TNF-α alone. These
data support a vast body of evidence that demonstrates that
IFN-γ can induce CXCL10 expression in a variety of cells
types, including granulocytes, T lymphocytes, bronchial
epithelial cells and keratinocytes [33, 34], while TNF-α is a
potent inducer for CXCL10 in hepatocytes [17]. Importantly,
in addition to these data, we could also show that Caco-2
cells stimulated with IL-1β up-regulate CXCL10 mRNA to a
significant level, whereas in HT29 and DLD1 cells,
induction of CXCL10 mRNA was less pronounced.
A number of authors have reported functional synergy
between TNF-α and IFN-γ in promoting gene expression
for proteins such as RANTES, IFN regulatory factor 1
(IRF-1), MIG and intercellular adhesion molecule-1[35–38]
Fig. 7 Transient transfection analysis of TGL-IP10 and TGL-IP10
κB2 mutant in IECs. TGL-IP-10 and TGL-IP10-κB2 Mut plasmid was
transiently transfected into a Caco-2, b HT29 and c DLD1. 24 h after
transfection, cells were stimulated with cytokines for 24 h, and
promoter activity was monitored by luciferase assay. Data were
normalised with renilla luciferase values. Data presented are the
means±SEM of three to five independent experiments done in
duplicates for each sample. Significant differences vs controls (C)
are indicated by an asterisk (p<0.05). Significant differences of wild
type vs mutant are indicated by a number sign (p<0.05). N.S. is not
significant
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synergy depends on the co-existence of TNF-α-responsive
NF-κB-binding sites and IFN-γ-responsive signal trans-
ducers and activators of transcription (STAT) protein-
binding elements within the promoters of the genes of
interest [35, 36]. In our study, when IFN-γ and TNF-α were
combined, the accumulation of CXCL10 mRNA and protein
was elevated compared to unstimulated cells or cells
stimulated with either cytokine alone, implying a synergistic
effect on transcription of the CXCL10 gene. A synergistic
effect by these two cytokines on CXCL10 expression was
also demonstrated in astrocytes, and this synergy has been
shown to be at least in part dependent on NF-κB activation
and binding to a NF-κB-binding site within the CXCL10
promoter [26].
The synergistic action of IL-1β with IFN-γ in IECs has
not been characterised so far. Recently, Takami et al. [39]
showed the synergistic induction of hepatocyte growth
factor in human skin fibroblasts by IL-1β+IFN-γ+IFN-γ
[39]. We here report for the first time that in intestinal
epithelial cell lines, IL-1β alone or in combination with
IFN-γ induced CXCL10 gene expression. In Caco-2 cells,
the combination led to an early synergistic induction of both
CXCL10 mRNA and protein compared to the combination
of IFN-γ+TNF-α. This early induction of CXCL10 mRNA
and protein by IL-1β+IFN-γ in Caco-2 might be due to the
early convergence of signalling pathways that activates
transcription factors like NF-κB, IRF-1, STAT1 or other
factors that mediate transcription factor interactions.
Transient transfections with human CXCL10 promoter
[26], in Caco-2, HT29 and DLD1 cells, showed that the
synergistic effect of IL-1β+IFN-γ and IFN-γ+TNF-α on
CXCL10 gene expression in these cell lines was indeed
because of the transcriptional synergy employed at the level
of the CXCL10 promoter. A number of studies had
revealed that cytokines like IL-1β, TNF-α or enteroinva-
sive bacteria and the bacterial cell wall product lipopoly-
saccharide induce the expression of several inflammatory
genes through the transcription factor NF-κB in IECs [40–
43]. To find out the signalling mechanism involved in
CXCL10 gene expression in IECs, we explored the role of
transcription factor NF-κB. Inhibition of NF-κBw i t h
BAY11-7082 clearly inhibited both CXCL10 mRNA and
protein induced by single cytokine alone or in combinations
in Caco-2, HT29 and DLD1 cells. Gel shift in Caco-2 could
confirm that NF-κB is activated and binds to consensus κB
oligonucleotides in cells treated with either IL-1β or TNF-
α alone and in combination with IFN-γ. It was shown
previously that the binding complex of NF-κB to the κB2-
binding site of the CXCL10 promoter contains the
homodimer of p65 [26]. In our study, super shift assays in
Caco-2 cells treated with IL-1β alone or in combination
with IFN-γ confirmed the presence of p65 in the complexes
bound to the consensus κB oligo nucleotides. In addition to
these experiments, transient transfection experiments with a
κB2 mutant of the CXCL10 promoter [26] clearly showed
that in Caco-2 cells, none of the cytokines and their
combinations were able to induce the CXCL10 promoter
activity. In HT29 cells, the combination of IFN-γ+TNF-α
led to a weaker induction of TGL-IP10κB-2 mutant activity,
whereas in DLD1cells, the combination of IL-1β+IFN-γ
and IFN-γ+TNF-α led to a weak induction of TGL-IP10
κB-2 mutant activity. Based on these data, we can conclude
that NF-κB plays a critical role in CXCL10 gene expression
Fig. 8 Gel shift and super shift analysis for NF-κB. Caco-2 cells were
seeded and grown for 24 h before pre-treating with BAY 11-7082
(10 μM) for 1 h and then stimulated with respective cytokines for
30 min; cells were then harvested, and nuclear extracts were prepared.
5 μg of nuclear extracts were used for gel shifts with a wild-type κB
oligonucleotide. Super shifts were performed with anti-p65 antibody.
Similar results were obtained in two separate experiments
Int J Colorectal Dis (2008) 23:305–317 315induced by cytokines in IECs, and this is mainly dependent
on the κB-2 site present in its promoter. Moreover, IFN-γ-
induced CXCL10 mRNA and protein secretion was
inhibited upon NF-kB inhibition.
Although the present results may reflect only a small
aspect in the overall concert of chemokines, it seems
apparent that the basic regulatory principles elucidated here
might be shared also by a number of other chemokine
genes like that of CCL19, which has recently been shown
to be regulated by multiple NF-κBa n dI R Ff a m i l y
transcription factors in human monocyte-derived dendritic
cells [44]. Recently, Hiroi M et.al. [45] showed that co-
operation between IFN-γ induced STAT1, and the consti-
tutively active or inducible NF-κB is necessary for the
transcriptional activity of IFN-γ-inducible genes like MIG
and CXCL10. Therefore, we suggest a similar mechanism
for IFN-γ-induced CXCL10 in IECs.
The responsiveness to cytokines might depend on the
state of differentiation. Schlottmann et. al. [46] recently
showed that in contrast to HT29 where IFNγ up-regulated
CXCL8 secretion, the same was unaffected in Caco-2 cells
or even down-regulated in primary colonic epithelial cells.
Future studies on chemokine regulation should therefore
include primary cells, keeping well in mind that the
presence of contaminating immune cells, culture conditions
and cell stress during isolation may influence results.
Taken together, our data suggest that while IFN-γ, TNF-
α and IL-1β may work individually through disparate
signalling pathways in CXCL10 gene regulation, a combi-
nation of these cytokines enhances transcription of the
CXCL10 gene in an NF-κB-dependent manner. The fact
that IL-1β via activation of NF-κB is able to mimic the
effect of TNF-α in augmenting CXCL10 expression might
be of importance in patients with IBD, who do not respond
to anti TNF-α antibody therapy. In those cases, an additional
inhibition of IL-1β might be desirable as a future therapy
option in treating IBD.
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